Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 1/20 | 0.35 |
| ▸ | METAP1 | P53582 | 1/20 | 0.35 |
| ▸ | MARS1 | P56192 | 9/20 | 0.35 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.35 |
| ▸ | ANPEP | P15144 | 1/20 | 0.33 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.33 |
| ▸ | BHMT | Q93088 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 2/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20996747 | 0.89 | RNPEP (0.42) | METAP2METAP1MARS1RNPEPANPEP | |
| SCHEMBL162031 | 0.89 | RNPEP (0.42) | METAP2METAP1MARS1RNPEPANPEP | |
| SCHEMBL5617582 | 0.89 | RNPEP (0.42) | METAP2METAP1MARS1RNPEPANPEP | |
| SCHEMBL6045793 | 0.89 | RNPEP (0.42) | METAP2METAP1MARS1RNPEPANPEP | |
| SCHEMBL4615397 | 0.86 | ALOX15 (0.46) | METAP2METAP1MARS1RNPEPANPEP | |
| SCHEMBL108278 | 0.86 | METAP2 (0.35) | METAP2METAP1MARS1RNPEPANPEP | |
| Hydrochloric Acid SCHEMBL8954857 | 0.85 | METAP2 (0.35) | METAP2METAP1MARS1RNPEPANPEP | |
| SCHEMBL997468 | 0.84 | RNPEP (0.38) | METAP2METAP1MARS1RNPEPANPEP | |
| SCHEMBL1352749 | 0.83 | SLC7A5 (0.42) | METAP2METAP1MARS1RNPEPANPEP | |
| SCHEMBL11531701 | 0.82 | RNPEP (0.37) | METAP2METAP1MARS1RNPEPANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0514509-B1 | COMPOSITION AND ITS PREPARATION PROCESS USING ANTIGEN CONJUGATED TO ENZYMATIC ACTIVITY FOR IMMUNOLOGICAL DIAGNOSIS AND CHAGAS' DISEASE IMMUNOLOGICAL DIAGNOSIS KITS, FOR INDIVIDUAL AND EPIDEMIOLOGICAL APPLICATION, BASED ON THAT COMPOSITION | FUNDACAO OSWALDO CRUZ (BR) | 2000-09-20 | — | — | EP | claimed |
| CN-113557292-B | Mutant proteases | 花王株式会社 | 2023-10-20 | — | — | CN | disclosed |
| CN-113557292-A | Mutant proteases | 花王株式会社 | 2021-10-26 | — | — | CN | disclosed |
| EP-2729570-A2 | REAGENT USABLE FOR THE ISOLATION AND/OR PURIFICATION OF NUCLEIC ACIDS | Qiagen GmbH (DE) | 2014-05-14 | — | — | EP | disclosed |
| EP-1466924-B9 | Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | PASTEUR INSTITUT (FR) | 2013-06-19 | — | — | EP | disclosed |
| WO-2013004710-A2 | REAGENT USABLE FOR THE ISOLATION AND/OR PURIFICATION OF NUCLEIC ACIDS | QIAGEN GMBH (DE) | 2013-01-10 | — | — | WO | disclosed |
| US-8173767-B2 | Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | INSTITUT PASTEUR (FR) | 2012-05-08 | — | — | US | disclosed |
| EP-1466924-B1 | Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | PASTEUR INSTITUT (FR) | 2011-05-04 | — | — | EP | disclosed |
| US-20100247618-A1 | Novel synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | INSTITUT PASTEUR | 2010-09-30 | — | — | US | disclosed |
| US-7364744-B2 | Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | INSTITUT PASTEUR (FR) | 2008-04-29 | — | — | US | disclosed |
| US-20050124540-A1 | Novel synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2005-06-09 | — | — | US | disclosed |
| EP-1466924-A1 | Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | INSTITUT PASTEUR (FR) | 2004-10-13 | — | — | EP | disclosed |
| EP-0514509-B1 | COMPOSITION AND ITS PREPARATION PROCESS USING ANTIGEN CONJUGATED TO ENZYMATIC ACTIVITY FOR IMMUNOLOGICAL DIAGNOSIS AND CHAGAS' DISEASE IMMUNOLOGICAL DIAGNOSIS KITS, FOR INDIVIDUAL AND EPIDEMIOLOGICAL APPLICATION, BASED ON THAT COMPOSITION | FUNDACAO OSWALDO CRUZ (BR) | 2000-09-20 | — | — | EP | disclosed |
| EP-0853667-A2 | BONE STIMULATING FACTOR | Gensci Regeneration Sciences Inc. (CA) | 1998-07-22 | — | — | EP | disclosed |
| WO-1997012036-A2 | BONE STIMULATING FACTOR | GENSCI REGENERATION SCIENCES INC. (CA) | 1997-04-03 | — | — | WO | disclosed |